메뉴 건너뛰기




Volumn 27, Issue 2, 2013, Pages 91-96

Refractory trigeminal neuralgia: Non-surgical treatment options

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BACLOFEN; BOTULINUM TOXIN; BUPIVACAINE; CARBAMAZEPINE; LAMOTRIGINE; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXCARBAZEPINE; PARACETAMOL; PIMOZIDE; PLACEBO; PREGABALIN; TRICYCLIC ANTIDEPRESSANT AGENT;

EID: 84876896151     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.1007/s40263-012-0023-0     Document Type: Article
Times cited : (55)

References (33)
  • 2
    • 51349094780 scopus 로고    scopus 로고
    • AAN-EFNS guidelines on trigeminal neuralgia management
    • 18721143 10.1111/j.1468-1331.2008.02185.x 1:STN:280: DC%2BD1cnivFCrtA%3D%3D
    • Cruccu G, Gronseth G, Alksne J, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008;15(10):1013-28.
    • (2008) Eur J Neurol , vol.15 , Issue.10 , pp. 1013-1028
    • Cruccu, G.1    Gronseth, G.2    Alksne, J.3
  • 3
    • 55249119499 scopus 로고    scopus 로고
    • Practice parameter: The diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies
    • 18716236 10.1212/01.wnl.0000326598.83183.04 1:STN:280: DC%2BD1cnksVyitQ%3D%3D
    • Gronseth G, Cruccu G, Alksne J, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology. 2008;71(15):1183-90.
    • (2008) Neurology , vol.71 , Issue.15 , pp. 1183-1190
    • Gronseth, G.1    Cruccu, G.2    Alksne, J.3
  • 4
    • 66749092091 scopus 로고    scopus 로고
    • Patient-reported outcomes in subjects with painful trigeminal neuralgia receiving pregabalin: Evidence from medical practice in primary care settings
    • 19522052 10.1111/j.1468-2982.2008.01792.x
    • Pérez C, Navarro A, Saldaña MT, et al. Patient-reported outcomes in subjects with painful trigeminal neuralgia receiving pregabalin: evidence from medical practice in primary care settings. Cephalalgia. 2009;29(7):781-90.
    • (2009) Cephalalgia , vol.29 , Issue.7 , pp. 781-790
    • Pérez, C.1    Navarro, A.2    Saldaña, M.T.3
  • 5
    • 65449138272 scopus 로고    scopus 로고
    • Trigeminal neuralgia treated with pregabalin in family medicine settings: Its effect on pain alleviation and cost reduction
    • 19299534 10.1177/0091270009333017
    • Pérez C, Saldaña MT, Navarro A, et al. Trigeminal neuralgia treated with pregabalin in family medicine settings: its effect on pain alleviation and cost reduction. J Clin Pharmacol. 2009;49(5):582-90.
    • (2009) J Clin Pharmacol , vol.49 , Issue.5 , pp. 582-590
    • Pérez, C.1    Saldaña, M.T.2    Navarro, A.3
  • 6
    • 77954446485 scopus 로고    scopus 로고
    • A fMRI evaluation of lamotrigine for the treatment of trigeminal neuropathic pain: Pilot study
    • 20492571 10.1111/j.1526-4637.2010.00859.x
    • Scrivani S, Wallin D, Moulton EA, et al. A fMRI evaluation of lamotrigine for the treatment of trigeminal neuropathic pain: pilot study. Pain Med. 2010;11(6):920-41.
    • (2010) Pain Med , vol.11 , Issue.6 , pp. 920-941
    • Scrivani, S.1    Wallin, D.2    Moulton, E.A.3
  • 7
    • 67650679279 scopus 로고    scopus 로고
    • World institute of medicine: 1. Trigeminal neuralgia
    • 10.1111/j.1533-2500.2009.00298.x
    • van Kleef M, van Genderen WE, Narouze S, et al. World institute of medicine: 1. Trigeminal neuralgia. Pain Pract. 2009;4:252-9.
    • (2009) Pain Pract , vol.4 , pp. 252-259
    • Van Kleef, M.1    Van Genderen, W.E.2    Narouze, S.3
  • 8
    • 58149157911 scopus 로고    scopus 로고
    • Subcutaneous botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin
    • 19004549 10.1016/j.pain.2008.10.005 1:CAS:528:DC%2BD1MXjvFSqtA%3D%3D
    • Gazerani P, Pedersen NS, Staahl C, et al. Subcutaneous botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin. Pain. 2009;141(1-2):60-9.
    • (2009) Pain , vol.141 , Issue.1-2 , pp. 60-69
    • Gazerani, P.1    Pedersen, N.S.2    Staahl, C.3
  • 9
    • 41549084998 scopus 로고    scopus 로고
    • Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia
    • 18378142 10.1016/j.jocn.2007.04.010 1:CAS:528:DC%2BD1cXktlCktbk%3D
    • Gomez-Arguelles JM, Dorado R, Sepulveda JM, et al. Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia. J Clin Neurosci. 2008;15(5):516-9.
    • (2008) J Clin Neurosci , vol.15 , Issue.5 , pp. 516-519
    • Gomez-Arguelles, J.M.1    Dorado, R.2    Sepulveda, J.M.3
  • 10
    • 34548861506 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain
    • 17662571 10.1016/j.jpainsymman.2006.12.015 1:CAS:528:DC%2BD2sXht1GksrnJ
    • Silver M, Blum D, Grainger J, et al. Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain. J Pain Symptom Manage. 2007;34(4):446-54.
    • (2007) J Pain Symptom Manage , vol.34 , Issue.4 , pp. 446-454
    • Silver, M.1    Blum, D.2    Grainger, J.3
  • 11
    • 79957502800 scopus 로고    scopus 로고
    • Lamotrigine for trigeminal neuralgia: Efficacy and safety in comparison with carbamazepine
    • 21621166 10.1016/j.jcma.2011.04.002 1:CAS:528:DC%2BC3MXmvFCqtbs%3D
    • Shaikh S, Yaacob HB, Abd Rahman RB. Lamotrigine for trigeminal neuralgia: efficacy and safety in comparison with carbamazepine. J Chin Med Assoc. 2011;74(6):243-9.
    • (2011) J Chin Med Assoc , vol.74 , Issue.6 , pp. 243-249
    • Shaikh, S.1    Yaacob, H.B.2    Abd Rahman, R.B.3
  • 12
    • 0030810189 scopus 로고    scopus 로고
    • Lamotrigine (lamictal) in refractory trigeminal neuralgia: Results from a double-blind placebo controlled crossover trial
    • 9415509 10.1016/S0304-3959(97)00104-8 1:CAS:528:DyaK2sXnt1eqsL0%3D
    • Zakrzewska JM, Chaudhry Z, Nurmikko TJ, et al. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 1997;73(2):223-30.
    • (1997) Pain , vol.73 , Issue.2 , pp. 223-230
    • Zakrzewska, J.M.1    Chaudhry, Z.2    Nurmikko, T.J.3
  • 14
    • 20044376310 scopus 로고    scopus 로고
    • Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)
    • 15733628 10.1016/j.pain.2004.12.010
    • Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1-2):29-36.
    • (2005) Pain , vol.114 , Issue.1-2 , pp. 29-36
    • Bouhassira, D.1    Attal, N.2    Alchaar, H.3
  • 15
    • 65449130768 scopus 로고    scopus 로고
    • Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia
    • 19475723 10.1111/j.1468-1331.2009.02585.x 1:STN:280: DC%2BD1MznsFeitg%3D%3D
    • Jorns TP, Johnston A, Zakrzewska JM. Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. Eur J Neurol. 2009;16(6):740-4.
    • (2009) Eur J Neurol , vol.16 , Issue.6 , pp. 740-744
    • Jorns, T.P.1    Johnston, A.2    Zakrzewska, J.M.3
  • 16
    • 33748870381 scopus 로고    scopus 로고
    • Intranasal lidocaine 8% spray for second-division trigeminal neuralgia
    • 16882684 10.1093/bja/ael180 1:CAS:528:DC%2BD28Xps1ygtLs%3D
    • Kanai A, Suzuki A, Kobayashi M, et al. Intranasal lidocaine 8% spray for second-division trigeminal neuralgia. Br J Anaesth. 2006;97(4):559-63.
    • (2006) Br J Anaesth , vol.97 , Issue.4 , pp. 559-563
    • Kanai, A.1    Suzuki, A.2    Kobayashi, M.3
  • 17
    • 33645453357 scopus 로고    scopus 로고
    • Subcutaneous sumatriptan for refractory trigeminal neuralgia
    • 16643550 10.1111/j.1526-4610.2006.00405.x (discussion 583-4)
    • Kanai A, Saito M, Hoka S. Subcutaneous sumatriptan for refractory trigeminal neuralgia. Headache. 2006;46(4):577-82. (discussion 583-4).
    • (2006) Headache , vol.46 , Issue.4 , pp. 577-582
    • Kanai, A.1    Saito, M.2    Hoka, S.3
  • 18
    • 33748937219 scopus 로고    scopus 로고
    • Sumatriptan alleviates pain in patients with trigeminal neuralgia
    • 16988562 10.1097/01.ajp.0000210917.18536.0d
    • Kanai A, Suzuki A, Osawa S, et al. Sumatriptan alleviates pain in patients with trigeminal neuralgia. Clin J Pain. 2006;22(8):677-80.
    • (2006) Clin J Pain , vol.22 , Issue.8 , pp. 677-680
    • Kanai, A.1    Suzuki, A.2    Osawa, S.3
  • 19
    • 38049020721 scopus 로고    scopus 로고
    • Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone
    • 18180639 10.1097/AJP.0b013e318158011a
    • Lemos L, Flores S, Oliveira P, et al. Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. Clin J Pain. 2008;24(1):64-75.
    • (2008) Clin J Pain , vol.24 , Issue.1 , pp. 64-75
    • Lemos, L.1    Flores, S.2    Oliveira, P.3
  • 20
    • 84856102576 scopus 로고    scopus 로고
    • Treatment of trigeminal neuralgia with bupivacaine HCL using a temporary epidural catheter and pain pump: Preliminary study
    • 21546257 10.1016/j.jcms.2011.03.022
    • Dergin G, Gocmen G, Sener BC. Treatment of trigeminal neuralgia with bupivacaine HCL using a temporary epidural catheter and pain pump: preliminary study. J Craniomaxillofac Surg. 2012;40(2):124-8.
    • (2012) J Craniomaxillofac Surg , vol.40 , Issue.2 , pp. 124-128
    • Dergin, G.1    Gocmen, G.2    Sener, B.C.3
  • 21
    • 38149117161 scopus 로고    scopus 로고
    • Efficacy and safety of high concentration lidocaine for trigeminal nerve block in patients with trigeminal neuralgia
    • 18036166 10.1111/j.1742-1241.2007.01568.x 1:CAS:528:DC%2BC3cXktFGgtLk%3D
    • Han KR, Kim C, Chae YJ, et al. Efficacy and safety of high concentration lidocaine for trigeminal nerve block in patients with trigeminal neuralgia. Int J Clin Pract. 2008;62(2):248-54.
    • (2008) Int J Clin Pract , vol.62 , Issue.2 , pp. 248-254
    • Han, K.R.1    Kim, C.2    Chae, Y.J.3
  • 22
    • 78650418411 scopus 로고    scopus 로고
    • Use of botulinum toxin A for drug-refractory trigeminal neuralgia: Preliminary report
    • 20674409 10.1016/j.tripleo.2010.04.043
    • Bohluli B, Motamedi MH, Bagheri SC, et al. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111(1):47-50.
    • (2011) Oral Surg Oral Med Oral Pathol Oral Radiol Endod , vol.111 , Issue.1 , pp. 47-50
    • Bohluli, B.1    Motamedi, M.H.2    Bagheri, S.C.3
  • 23
    • 84861800887 scopus 로고    scopus 로고
    • Botulinum toxin type A for the treatment of trigeminal neuralgia: Results from a randomized, double-blind, placebo-controlled trial
    • 22492424 10.1177/0333102412441721
    • Wu CJ, Lian YJ, Zheng YK, et al. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia. 2012;32(6):443-50.
    • (2012) Cephalalgia , vol.32 , Issue.6 , pp. 443-450
    • Wu, C.J.1    Lian, Y.J.2    Zheng, Y.K.3
  • 24
    • 64149128169 scopus 로고    scopus 로고
    • Comment on AAN-EFNS guidelines on trigeminal neuralgia management
    • 19405206 10.1111/j.1468-1331.2009.02584.x 1:STN:280: DC%2BD1MzhtFSmtw%3D%3D
    • Teive HA, Piovesan EJ, Kowacs PA, et al. Comment on AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2009;16(5):e105.
    • (2009) Eur J Neurol , vol.16 , Issue.5 , pp. 105
    • Teive, H.A.1    Piovesan, E.J.2    Kowacs, P.A.3
  • 25
    • 52949097981 scopus 로고    scopus 로고
    • Beneficial effects of botulinum toxin type A in trigeminal neuralgia
    • 18813708 10.1590/S0004-282X2008000400012
    • Zúñiga C, Díaz S, Piedimonte F, et al. Beneficial effects of botulinum toxin type A in trigeminal neuralgia. Arq Neuropsiquiatr. 2008;66(3A):500-3.
    • (2008) Arq Neuropsiquiatr , vol.66 , Issue.3 A , pp. 500-503
    • Zúñiga, C.1    Díaz, S.2    Piedimonte, F.3
  • 26
    • 27144451747 scopus 로고    scopus 로고
    • An open study of botulinum-A toxin treatment of trigeminal neuralgia
    • 16247065 10.1212/01.wnl.0000180940.98815.74 1:CAS:528:DC%2BD2MXhtV2jsbjO
    • Piovesan EJ, Teive HG, Kowacs PA, et al. An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology. 2005;65(8):1306-8.
    • (2005) Neurology , vol.65 , Issue.8 , pp. 1306-1308
    • Piovesan, E.J.1    Teive, H.G.2    Kowacs, P.A.3
  • 27
    • 23644431890 scopus 로고    scopus 로고
    • Botulinum toxin and intractable trigeminal neuralgia
    • 16062093 10.1097/01.wnf.0000172497.24770.b0
    • Türk U, Ilhan S, Alp R, et al. Botulinum toxin and intractable trigeminal neuralgia. Clin Neuropharmacol. 2005;28(4):161-2.
    • (2005) Clin Neuropharmacol , vol.28 , Issue.4 , pp. 161-162
    • Türk, U.1    Ilhan, S.2    Alp, R.3
  • 28
    • 0036175202 scopus 로고    scopus 로고
    • The use of botulinum toxin for the treatment of chronic facial pain
    • 14622850 10.1054/jpai.2002.27142
    • Borodic GE, Acquadro MA. The use of botulinum toxin for the treatment of chronic facial pain. J Pain. 2002;3(1):21-7.
    • (2002) J Pain , vol.3 , Issue.1 , pp. 21-27
    • Borodic, G.E.1    Acquadro, M.A.2
  • 29
    • 26444469528 scopus 로고    scopus 로고
    • Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A
    • 16002144 10.1016/j.neuro.2005.01.017 1:CAS:528:DC%2BD2MXhtFWhsLnJ
    • Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005;26(5):785-93.
    • (2005) Neurotoxicology , vol.26 , Issue.5 , pp. 785-793
    • Aoki, K.R.1
  • 30
    • 80054102660 scopus 로고    scopus 로고
    • Updates on the antinociceptive mechanism hypothesis of botulinum toxin A
    • 21999893 10.1016/j.parkreldis.2011.06.013
    • Aoki KR, Francis J. Updates on the antinociceptive mechanism hypothesis of botulinum toxin A. Parkinsonism Relat Disord. 2011;17(Suppl. 1):S28-33.
    • (2011) Parkinsonism Relat Disord , vol.17 , Issue.SUPPL. 1
    • Aoki, K.R.1    Francis, J.2
  • 31
    • 11444254396 scopus 로고
    • The mechanism of the pain in trigeminal neuralgia
    • 13642075 10.1136/jnnp.22.1.36 1:STN:280:DyaG1M%2FntFKrsg%3D%3D
    • Kugelberg E, Lindblom U. The mechanism of the pain in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1959;22(1):36-43.
    • (1959) J Neurol Neurosurg Psychiatry , vol.22 , Issue.1 , pp. 36-43
    • Kugelberg, E.1    Lindblom, U.2
  • 32
  • 33
    • 65449178130 scopus 로고    scopus 로고
    • Trigeminal neuralgia and pain related to multiple sclerosis
    • 19171430 10.1016/j.pain.2008.12.026 1:STN:280:DC%2BD1MzjvVKhtQ%3D%3D
    • Cruccu G, Biasiotta A, Di Rezze S, et al. Trigeminal neuralgia and pain related to multiple sclerosis. Pain. 2009;143(3):186-91.
    • (2009) Pain , vol.143 , Issue.3 , pp. 186-191
    • Cruccu, G.1    Biasiotta, A.2    Di Rezze, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.